HER2 overexpression was correlated with the various clinicopathological parameters in gastric cancer patients: male sex, proximally located tumour, advanced stage, lymph node metastasis, distant metastasis, poorly differentiated tumour, and intestinal subtype (Lei et al., 2017). This evidence concerns the gene ERBB2 and neoplasm.